WASHINGTON (AP) — Byron Buxton hit a three-run homer, Brooks Lee drove in three runs and Taj Bradley struck out eight in six solid innings to help the Minnesota Twins beat the Washington Nationals ...

DETROIT — Payton Tolle pitched seven innings of two-run ball, Jarren Duran hit a three-run home run and the Boston Red Sox used a five-run seventh inning to beat the Detroit Tigers 5-4 on Monday night ...

SAN DIEGO (AP) — Pete Crow-Armstrong hit a three-run homer and the Chicago Cubs beat the San Diego Padres 8-3 on Tuesday night to stop their three-game slide. Dansby Swanson and Nico Hoerner each had ...

You know the long run is the cornerstone workout of a marathon training plan. But determining how far you should go can seem confusing. Coaches even debate whether it’s worth running more than three ...

Gavin Sheets' second homer of the game was a three-run, game-ending shot in the ninth inning, as the San Diego Padres beat the Colorado Rockies 5-2 on Friday night. Colorado's Juan Mejia (0-2) came on ...

Shohei Ohtani has officially been welcomed to the new MLB year after hitting his first home run of the 2026 season. Ohtani looks like he's back in form following a three-run home run as the Los ...

April 1 - Danny Jansen hit a three-run homer for one of his three hits as the Texas Rangers beat the host Baltimore Orioles 8-5 on Tuesday night. Ezequiel Duran and Corey Seager also homered for the ...

Carlos Correa put Houston on top with a three-run homer and Christian Vázquez added a solo shot to lead the Astros to a 6-4 win over the Boston Red Sox to complete a three-game sweep. Houston Astros' ...

CINCINNATI (AP) Eugenio Suarez hit a three-run home run and the Cincinnati Reds beat the Boston Red Sox 3-2 on Sunday to win their season-opening series. Suarez’s homer, his first since rejoining the ...

Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...